Sensomedical Sp. z o.o. sp. k. (Poland)

Main Activities: Pharmacies and Drug Stores

Secondary Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Medical Equipment and Supplies Manufacturing | Computer and Computer Peripheral Equipment and Software Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Automobile Dealers | Clothing Stores | Convention and Trade Show Organizers | All Other Miscellaneous Schools and Instruction | Electronic and Precision Equipment Repair and Maintenance

Full name: Sensomedical Sp. z o.o. sp. k.

Profile Updated: September 10, 2025

Sensomedical Sp. z o.o. sp. k. is an enterprise based in Poland. Its main office is in Cieszyn. It operates in the Pharmacies and Drug Stores industry. It was incorporated on March 13, 2014. There are currently 1 (2015) people employed by Sensomedical Sp. z o.o. sp. k.. Its’ total assets recorded a growth of 60.7%.

Headquarters
Ul. Stawowa 71
Cieszyn; Slaskie; Postal Code: 43-400

Contact Details: Purchase the Sensomedical Sp. z o.o. sp. k. report to view the information.

Basic Information

Total Employees:

Purchase the Sensomedical Sp. z o.o. sp. k. report to view the information.

Financial Auditors:

Purchase the Sensomedical Sp. z o.o. sp. k. report to view the information.

Incorporation Date:

March 13, 2014

Key Executives

Purchase this report to view the information.

Associate

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Sensomedical Sp. z o.o. sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-22.62%▼

EBITDA

-22.46%▼

Net Profit (Loss) for the Period

-29.88%▼

Total Assets

60.7%▲

Similar companies